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Summary
 
We have previously shown that a tyrosine to leucine replacement in the transmembrane region
of T cell receptor (TCR)-
 
b
 
 results in a deficient induction of CD95-L and apoptosis upon
TCR triggering in a transfected T cell line. By contrast, interleukin (IL)-2 production and the
expression of CD25 and CD69 were normally induced. Since the mutation in TCR-
 
b
 
 also re-
sulted in impaired association of CD3-
 
z
 
, it was proposed that this chain is specifically required
for the induction of apoptosis. We now show that the deficient induction of CD95-L and apop-
tosis does not derive from a general lower production of second messengers, since intracellular
Ca
 
2
 
1
 
 fluxes and tyrosine phosphorylation of total proteins were elicited at wild-type levels.
Unlike in T cell clones stimulated with partial agonists, both p21 and p18 forms of tyrosine-
phosphorylated CD3-
 
z
 
 were detected, although the overall level of tyrosine-phosphorylated
CD3-
 
z
 
 was low. More strikingly, inducible association of ZAP70 to CD3-
 
z
 
 was strongly in-
hibited, despite a normal induction of ZAP70 tyrosine phosphorylation. Finally, ZAP70 was
not concentrated near the plasma membrane in the apoptosis-deficient cells. These results sug-
gest that CD3-
 
z
 
 is necessary for engagement of a specific signaling pathway leading to CD95-L
expression that also needs the recruitment of ZAP70.
 
T
 
he TCR complex is composed of two functionally
distinct modules. Whereas the TCR-
 
a
 
/
 
b
 
 heterodimer
is responsible for recognition of the antigen/MHC ligand,
the cytoplasmic tails of the CD3 components (CD3-
 
g
 
,
CD3-
 
d
 
, CD3-
 
e
 
, CD3-
 
z
 
) are responsible for signal trans-
duction. Thus, engagement of the TCR initiates a cascade
of signal transduction events that trigger T cell proliferation
and differentiation. It seems that the earliest activation
event measurable is the recruitment and activation of non-
receptor tyrosine kinases of the Src family that in turn
phosphorylate the tyrosine residues of the immunoreceptor
tyrosine-based activation motifs (ITAMs)
 
1
 
 present in the
cytoplasmic tails of the CD3 chains (1–4). CD3-
 
g
 
, CD3-
 
d
 
,
and CD3-
 
e
 
 each contain one ITAM, whereas CD3-
 
z
 
 con-
tains three. It has been proposed that the multiplicity of
ITAMs in the TCR complex may serve primarily to am-
plify TCR activation signals. Once phosphorylated, the
ITAMs become sites for high-affinity binding of tyrosine
kinases of the Syk family, mainly of ZAP70 in T cells,
through their tandem src homology 2 (SH2) domains (5–
8). After binding to the phosphorylated ITAMs, ZAP70
becomes tyrosine phosphorylated and activated by a src ki-
nase, which is thought to be primarily Lck (9). Once acti-
vated, ZAP70 probably autophosphorylates on multiple ty-
rosine residues (2), thus generating docking sites for SH2
domain–containing proteins, including Lck and Vav (10,
11). Subsequently, downstream effector functions are trig-
gered, including the mobilization of intracellular Ca
 
2
 
1
 
 and
the transport to the nucleus of an array of transcription fac-
tors that drive, among others, cytokine gene expression and
programmed cell death.
Programmed cell death and its accompanying morpho-
logical changes, called apoptosis, are active processes by
which unnecessary or harmful cells are self-eliminated in
multicellular organisms (12, 13). Evidence has accumulated
that signaling through the TCR complex can elicit apopto-
sis in immature thymocytes, human leukemic T cells, and
mature peripheral T cells (14). This mechanism contributes
 
1
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to the downregulation of ongoing peripheral immune re-
sponses and to the establishment of tolerance to self-anti-
gens. Engagement of the TCR frequently triggers both
proliferation and death of mature cells, raising the question
of how these two outcomes are differentially regulated.
Several members of the growing families of the TNF and
TNFR have been shown to be involved in mediation of
the final stages of programmed cell death (for recent re-
views see references 15–17). Of these members, it seems
that the fas-ligand (CD95-L), TNF, and their receptors (fas
or CD95, TNFR1, and TNFR2) are the most important
mediators of apoptosis in peripheral T cells (18, 19). Stimu-
lation of the TCR complex results in upregulation of
CD95 and CD95-L, and subsequent binding of CD95 to
its ligand results in the direct activation of a cascade of pro-
teases that finally lead to apoptosis (for review see refer-
ences 16, 17). Although this process has been and is still
under intense scrutiny, the activation pathways that lead to
CD95 and CD95-L expression are mostly unknown. A re-
cently cloned gene, TDAG51, seems necessary for TCR
induction of CD95 in T cell hybridomas (20). On the
other hand, it is known that the induction of CD95-L gene
transcription is nuclear factor of activated cells (NFAT) de-
pendent (21–24). Indeed, the recent characterization of the
CD95-L promoter has shown the presence of an inducible
NFAT-binding site that could be responsible for the regu-
lation of CD95-L expression in T cells (25).
It was recently described that cross-linking of a Tac–
 
z
 
chimera results in induction of apoptosis in a transfected
murine T hybridoma, suggesting that CD3-
 
z
 
 is capable of
inducing CD95-L expression on its own (26). Further-
more, Combadière et al. (27) showed in transgenic mice
that the CD3-
 
z
 
 chain, through one of its ITAMs, might
play unique roles in TCR responses leading to apoptosis by
engaging specific signaling pathways. In addition, we have
previously described that transfection of a transmembrane
tyrosine to leucine mutant of TCR-
 
b
 
 into TCR-
 
b
 
–nega-
tive Jurkat cells results in a defective association of CD3-
 
z
 
to the other subunits of the TCR complex (28). Compared
with cells transfected with wild-type TCR-
 
b
 
, the mutant
cells responded normally to TCR cross-linking by IL-2 se-
cretion, TCR downregulation, and expression of the acti-
vation-induced receptors CD25 and CD69. By contrast,
compared with wild-type cells, mutant cells were resistant
to programmed death after TCR cross-linking. This defec-
tive induction of apoptosis was found to be based on a de-
fective induction of CD95-L. On the basis of this evidence,
we suggested that CD3-
 
z
 
 is needed for activation of a sig-
naling pathway leading to expression of CD95-L and apop-
tosis. We now show that the defective signaling in the
mutant cells is not derived from a generalized lower pro-
duction of second messengers, including intracellular Ca
 
2
 
1
 
increases and total protein tyrosine phosphorylation, but
must be derived from a specific defect in a signaling path-
way. In this regard, we have found that both a defective as-
sociation of ZAP70 to CD3-
 
z
 
 and a defective recruitment
of ZAP70 to a near-plasma membrane location might be
responsible for the apoptosis-defective phenotype.
 
Materials and Methods
 
Cell Lines.
 
The wild-type and mutant cell lines were ob-
tained by reconstitution of the TCR-
 
b
 
–negative Jurkat variant
31.13 (generously provided by Dr. A. Alcover, Institut Pasteur,
Paris, France), with either a wild-type V
 
b
 
3
 
1
 
 TCR-
 
b
 
 cDNA de-
rived from the T cell clone HA1.7, or with a mutant TCR-
 
b
 
cDNA that contains a transmembrane tyrosine to leucine muta-
tion (28).
 
DNA Constructs and Antibodies.
 
The plasmid encoding for the
chimeric protein consisting of the extracellular and transmem-
brane domain of human IL-2R 
 
a
 
 chain and the intracytoplasmic
domain of CD3-
 
z
 
 was generously given by Dr. F. Letourneur
(29). The ZAP70–green fluorescent protein (GFP) construct was
prepared by PCR using as template the HA-tagged ZAP70
cDNA construct generously provided by Dr. A. Weiss (Univer-
sity of California at San Francisco, CA). The PCR primers used
added a EcoRI site in 5
 
9
 
 and a BamHI site in 3
 
9
 
. The PCR prod-
uct was digested and subcloned in the plasmid pEGFP-N1
(CLONTECH Laboratories, Inc., Palo Alto, CA) previously di-
gested with the same restriction enzymes.
The antibody 448, specific for CD3-
 
z
 
, was generated by im-
munization of a New Zealand rabbit with a synthetic peptide
corresponding to the 109–132-amino acid sequence of human
CD3-
 
z
 
 coupled to KLH, as previously described (30). The anti-
ZAP70–specific rabbit antiserum ZAP4, as well as the antiserum
specific for human Vav, were generously donated by Dr. S. Ley
(Medical Research Council, Mill Hill, London, UK) (31). The
rabbit anti–human PLC-
 
g
 
1 was kindly given by Dr. Peter Parker
(Imperial Cancer Research Fund, London, UK). The anti-V
 
b
 
3
antibody Jovi.3 was a generous gift of Dr. M. Owen (Imperial
Cancer Research Fund, London, UK). The anti-Tac antibody
MAR108 was generously provided by Dr. Miguel López Botet
(Hospital de la Princesa, Madrid, Spain). The anti-CD3-
 
e
 
 and
anti-CD3-
 
d
 
 antibodies, APA1/1 and APA1/2, respectively, have
been previously described (32). The anti-CD3 antibodies OKT3
and UCHT1 were purchased from Ortho Diagnostics (Raritan,
NJ) and Immunokontact (Bioggio, Switzerland), respectively.
The anti-V
 
b
 
8 and anti-CD95 antibodies were from PharMingen
(San Diego, CA). The anti-phosphotyrosine antibody 4G10 was
acquired from Upstate Biotechnology Inc. (Lake Placid, NY) and
the anti-phosphotyrosine antibody PY20 from Transduction Lab-
oratories (Lexington, KY).
 
Cytokine Assays.
 
A total of 5 
 
3 
 
10
 
5
 
 cells/ml were stimulated
with soluble 
 
Staphylococcal enterotoxin
 
 B (SEB; 10 
 
m
 
g/ml) for 48 h
or with soluble UCHT1 (10 
 
m
 
g/ml) plus PMA (10 ng/ml) for 24 h.
The IL-2 content in the supernatants of these cultures was deter-
mined by a commercial ELISA, following the manufacturer’s in-
structions (Genzyme Corp., Boston, MA). IFN-
 
g
 
 was also de-
tected in the same supernatants by ELISA using the mAbs 43.11
and 45.11 (kindly donated by Dr. Sefik Alkan, Novaitis, Basel,
Switzerland) as previously described (33). In both cases, superna-
tants were tested in duplicate and OD values were converted to
U/ml by comparison with standard curves determined with re-
combinant human IL-2 (Hoffman-La Roche, Nutley, NY) and
IFN-
 
g
 
 (Genzyme Corp.). The culture supernatants were diluted
to make the OD values fall in the linear range of the curves.
 
Analysis of Intracellular Ca
 
2
 
1
 
 
 
Fluxes.
 
A total of 10
 
7
 
 cells/ml
were washed three times with serum-free RPMI and loaded with
5 
 
m
 
g/ml fura-2AM (Sigma Chemical Co., St. Louis, MO) for 1 h
at 37
 
8
 
C in the dark. They were then washed twice with RPMI,
resuspended at 5 
 
3
 
 10
 
6
 
 cells/ml in PSS-Ca
 
2
 
1
 
 (140 mM NaCl, 4.6
mM KCl, 2 mM CaCl
 
2
 
, 10 mM MgCl
 
2
 
, 10 mM 
 
D
 
-glucose, 10
mM Hepes, pH 7.4), placed in a cuvette, and allowed to equili- 
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brate in a Perkin-Elmer fluorimeter at 37
 
8
 
C under gentle stirring
until the baseline was stable. The excitation wavelength was of
339 nm and emission was measured at 510 nm. Primary and sec-
ondary fluorimetric responses were recorded after stimulation
with 10 
 
m
 
g/ml OKT3 and subsequent cross-linking with 30 
 
m
 
g/ml
polyclonal rabbit anti–mouse Ig, respectively. Triton X-100
(Sigma Chemical Co.) was added to 1% to establish a maximum
signal (F
 
max
 
), followed by EGTA to 100 mM to establish a mini-
mum (F
 
min
 
). Absolute Ca
 
2
 
1
 
 concentration increases were calcu-
lated as described (34).
 
Activation, Immunoprecipitation and Immunoblotting.
 
For activa-
tion 3 
 
3
 
 10
 
7
 
 cells per time point were collected, washed, and re-
suspended in 1 ml of RPMI supplemented with 10 mM Hepes,
pH 7.4 and prewarmed at 37
 
8
 
C for 15 min. Afterwards, 10 
 
m
 
g/ml
OKT3 or SEB (Sigma Chemical Co.) was added and the cells
were collected at different time intervals by brief centrifugation in
an Eppendorf centrifuge. Each cell pellet was subsequently resus-
pended in 1 ml of 1% Brij96 lysis buffer (1% Brij96, 140 mM
NaCl, 10 mM Tris-HCl, pH 7.8, 10 mM iodoacetamide, 1 mM
PMSF, 1 
 
m
 
g/ml leupeptin, 1 
 
m
 
g/ml aprotinin, 1 mM sodium
orthovanadate, 20 mM sodium fluoride) and maintained for 30
min on ice. The cell lysates were centrifuged at 12,000 
 
g
 
 for 15
min and the supernatants were subjected to immunoprecipitation
with protein A– or G–Sepharose beads precoated with specific
antibodies as previously described (32). The immunoprecipitates
were subjected to SDS-PAGE and the electrophoresed proteins
were transferred to a nitrocellulose membrane (Bio-Rad Labora-
tories, Hercules, CA) by standard procedures. The membrane
was blocked in a solution of 10% nonfat dry milk in PBS for 1 h
at room temperature. The membrane was rinsed three times with
100 ml of 0.1% Tween 20 in PBS and incubated with the appro-
priate dilutions of the specific antibodies in PBS-Tween for 1 h at
room temperature. The membrane was then washed five times
with 100 ml PBS-Tween and subsequently incubated with a per-
oxidase-labeled sheep anti–mouse Ig (Amersham International,
Little Chalfont, UK) in PBS-Tween for 1 h. After six washes
with 100 ml PBS-Tween the membrane was processed by the
enhanced chemiluminescence (ECL) method according to the
manufacturer’s specifications (Amersham International).
To analyze tyrosine phosphorylation of total proteins, an ali-
quot of the 1% Brij96 cell lysate containing the equivalent of
300,000 cells was mixed with an equal volume of ice-cold ace-
tone and kept on ice for 10 min. The samples were centrifuged at
12,000 
 
g
 
 for 10 min, air-dried and resuspended in sample buffer
for SDS-PAGE.
 
In Vitro Kinase Assay.
 
For the in vitro kinase assay, the anti-
ZAP70 immunoprecipitates were washed six times with lysis
buffer and once with kinase buffer (100 mM NaCl, 50 mM
Hepes, pH 7.5, 5 mM MgCl
 
2
 
, 5 mM MnCl
 
2
 
, 1 mM sodium
orthovanadate). The beads were resuspended in 50 
 
m
 
l kinase
buffer plus 5 
 
m
 
M cold ATP and 10 
 
m
 
Ci 
 
g
 
-[
 
32
 
P]ATP (5,000 Ci/
mmol; Amersham International) and incubated for 20 min at
room temperature. The beads were then washed three times with
lysis buffer containing 20 mM EDTA, and finally were boiled in
Laemmli sample buffer and the samples subjected to SDS-PAGE.
To measure the phosphorylation of an exogenous substrate, 8 
 
m
 
g
of purified bovine brain tubulins (generously given by Dr. J.
Avila, Centro de Biología Molecular, Madrid, Spain) were added
to the kinase reaction.
 
Confocal Microscopy.
 
Wild-type and mutant cells at 10
 
6
 
/ml in
RPMI were stimulated with 10 
 
m
 
g/ml OKT3 for 1 min at 378C
and then diluted in 10 ml ice-cold PBS and centrifuged onto
coverslips. The cells were fixed in 2% paraformaldehyde in PBS
for 20 min at room temperature and subsequently blocked and
permeabilized in PBS containing 1% BSA and 0.1% saponin. The
cells were then stained with a 1:1,000 dilution of ZAP4 antibody
in blocking buffer for 30 min at room temperature, followed by
staining with a mixture of a Texas red–labeled goat anti–rabbit Ig
and fluoresceinated goat anti–mouse Ig antibodies (Southern Bio-
technology Associates Inc., Birmingham, AL). The coverslips
were subsequently washed and mounted in mowiol as described
(35). The preparations were examined in a Zeiss confocal micro-
scope.
Transient Transfections. For transient transfection, 5 3 106
cells were collected, resuspended in 500 ml of RPMI plus 20%
FCS and transferred to a 0.4-mm electroporation cuvette (Bio-
Rad Laboratories). A total of 50 mg of plasmid DNA was added
and the cells were incubated for 15 min at room temperature be-
fore electroporation was performed at 260 V and 960 mF in a
Bio-Rad Gene Pulser. After electroporation, the cells were al-
lowed to stand for 2 min and then centrifuged and put in culture.
Expression of the transfected protein was usually examined 24 h
after transfection.
Apoptosis Assays. A total of 105 transfected cells/well were
plated 24 h after electroporation on 96-well plates (Costar Corp.,
Cambridge, MA) precoated with variable concentrations of anti-
CD3 or anti-Tac antibodies. To estimate the number of cells in
apoptosis, 20 h later they were stained with biotinylated annexin
V (Boehringer Mannheim GmbH, Mannheim, Germany) fol-
lowed by staining with PE-labeled streptavidin (Southern Bio-
technology Associates Inc.). To distinguish the transfected from
the nontransfected cells, the samples were double stained with
anti-Tac antibody, followed by a fluoresceinated goat anti–mouse
Ig antibody (Southern Biotechnology Associates Inc.) and ana-
lyzed in an EPICS-XL flow cytometer (Coulter Immunology,
Hialeah, FL). ZAP-GFP transfected cells were single stained with
biotinylated annexin V– and PE-labeled streptavidin and sub-
jected to two-color analysis. The level of apoptosis within the
transfected population was estimated as the percentage of annexin
V–positive cells.
Results
Apoptosis but Not Cytokine Release Is Defective in Jurkat T
Cell Clones Expressing a TCR-b Mutant That Impairs CD3-z
Association. The ability of the TCR complex to elicit dif-
ferent activation events in several Jurkat cell clones that ex-
press either wild-type TCR-b or a transmembrane tyrosine
to leucine mutant have been studied. Mutant clones that
expressed similar amounts of the TCR complex to those of
wild-type transfectants (Fig. 1 A) were chosen for compar-
ative purposes. A comparison of the ability of wild-type
and mutant clones to secrete cytokines and to die by apop-
tosis upon stimulation of the TCR complex with SEB is
shown in Fig. 1 B. Strikingly, although the mutant clone
C2 released similar amounts of IL-2 and IFN-g to the
wild-type clone B7, it was, however, refractory to activa-
tion-induced cell death. Indeed, as shown in Fig. 1 B, the
mutant cell clone was defective in the induction of CD95-
ligand, although it did maintain an intact apoptosis machin-
ery that could be triggered by direct stimulation of CD95
(CH11 stimulation). These data suggest that, as previously
shown (28), the mutation in the transmembrane domain of1182 Impaired ZAP70/CD3-z Interaction in Apoptosis-resistant Cells
TCR-b results in a selective defect in the induction of
CD95-L, but not of IL-2 and IFN-g.
Despite the high cell surface expression of the TCR–
CD3 complex in the wild-type and mutant cell clones
studied (Fig. 1 A and reference 28) we found that the asso-
ciation of CD3-z to the remaining chains of the complex is
impaired. Thus, immunoprecipitation with an anti–TCR-b
antibody from 1% Brij96 lysates of the mutant cell clone
(C2) resulted in the coprecipitation of very low amounts of
CD3-z compared with those coprecipitated from a wild-
type clone (G7, Fig. 2, A and B). However, normal amounts
of CD3-d and CD3-e chains were coprecipitated (Fig. 2
A), suggesting that the TCR–CD3 complex in the mutant
clone is assembled without CD3-z. Thus, these data confirm
those obtained by surface iodination (28), where an other-
wise complete TCR–CD3 complex was shown to be ex-
pressed at the cell surface in the almost complete absence of
CD3-z. As a control for the expression of CD3-z in the
mutant clone, aliquots of the total lysates from the wild-
type and the mutant clones were subjected to SDS-PAGE
and to immunoblotting with anti-z antibody. The result
showed that, despite the low association of CD3-z to the
TCR complex in the mutant clone, the total levels of CD3-z
were normal (Fig. 2 B). The defective association of CD3-z
was not reverted in the mutant clone upon TCR cross-
linking with an anti-CD3 antibody while, in the wild-type
clone, the amount of CD3-z associated to the TCR com-
plex seems to decrease upon activation (Fig. 2 B), suggest-
ing this chain may be inducibly internalized and degraded,
as recently proposed (36, 37).
According to these data, the defective induction of CD95-L
upon stimulation of the TCR–CD3 complex could be the
result of weak association of the CD3-z chain. By contrast,
a high level of CD3-z association would not be required
for activation of the signaling mechanisms leading to secre-
tion of IL-2 and other cytokines, as was previously estab-
lished in murine T cell hybridomas (38).
Defective CD95-L Expression Does Not Result from a Gener-
alized Decrease of Second Messengers. Since the CD3-z ho-
modimer contributes with six ITAMs to the TCR complex,
it could be hypothesized that a stimulation of a complex
with low levels of associated CD3-z would elicit lower lev-
els of intracellular second messengers. Thus, if the threshold
of second messengers required for CD95-L were higher
than for IL-2 induction, then a defective recruitment of
CD3-z to the TCR complex should result in a selective
defect on CD95-L induction. Alternatively, CD3-z could
trigger a special activation pathway required for the induc-
tion of CD95-L but not for cytokines. To investigate
Figure 1. TCR-b mutant clones release normal levels of cytokines but
are resistant to TCR-mediated apoptosis. (A) Flow cytometry analysis of
clones expressing either wild-type (B7) or mutant TCR-b (C2) chains.
B7 and C2 cells were analyzed for the cell surface expression of the CD3
complex (antibody UCHT1), the transfected TCR-b chain (Vb3, contin-
uous line), the Jurkat endogenous TCR-b (Vb8, broken line) and CD95.
(B) Wild-type B7 (filled bars) and mutant C2 cells (open bars) were stimu-
lated with 10 mg/ml SEB for 48 h at 378C. The percentages of cells with
sub-G1 amounts of DNA were quantified by flow cytometry after stain-
ing the cells with propidium iodide. Secretion of IL-2 and IFN-g was
measured by ELISA in the supernatants of stimulated cells. CD95-L
mRNA expression of cells stimulated for 3 h was determined by North-
ern blotting and quantified by densitometry. Cells were also stimulated
with the anti-CD95 antibody CH11 to demonstrate that the apoptotic
machinery works well in both types of cell. Values are expressed in arbi-
trary units as a result of the normalization of the wild-type (WT) values to 1.1183 Sahuquillo et al.
whether the ability of mutant cells to produce second mes-
sengers is diminished, intracytosolic Ca21 increases were
recorded in two wild-type and two mutant clones. As
shown in Fig. 3, all four clones responded similarly to anti-
CD3 stimulation before and after cross-linking with a sec-
ond anti-mouse Ig antibody. Although there were some
differences in the intensity of the Ca21 signal and in the re-
sponse to the cross-linking antibody, these differences
could not be ascribed to wild-type or mutant phenotypes.
Similar results were obtained upon stimulation with SEB
(data not shown).
Despite the normal Ca21 fluxes induced upon TCR
cross-linking, it was possible that the level of tyrosine phos-
phorylation in total proteins was diminished in the clones
that have a low level of CD3-z associated to the TCR
complex. This was not the case and, indeed, stimulation of
the TCR complex with antibodies (Fig. 4) or with super-
antigen (not shown) did not result in lower tyrosine phos-
phorylation. On the contrary, activation-induced tyrosine
phosphorylation reached consistently higher levels in mu-
tant clones. Interestingly, tyrosine phosphorylation of total
proteins was considerably higher in nonactivated mutant
than in wild-type cells. At present, we do not know what
could be the cause of this effect. Some protein bands were
readily identified after reprobing the membrane with spe-
Figure 2. CD3-z is loosely as-
sociated to the TCR–CD3 com-
plex in the apoptosis-defective
mutant cells. (A) Wild-type G7
and mutant C2 cell clones were
lysed in 1% Brij96 immunopre-
cipitation buffer and the cell ly-
sates were immunoprecipitated
(Ip) with either anti–TCR-b an-
tibody Jovi.3 or anti-CD3-z
antibody 448. The immunopre-
cipitates were subjected to SDS-
PAGE, transferred to nitrocellu-
lose and immunoblotted with
anti-CD3-z antibody 448, anti-
CD3-e antibody APA1/1 and
anti-CD3-d antibody APA1/2.
(B) Wild-type G7 and mutant
C2 cells were stimulated with 10
mg/ml OKT3 for the indicated
times (in min), and then lysed in
1% Brij96. Immunoprecipita-
tion was performed with anti-
Vb3 antibody Jovi.3. The immunoprecipitates were resolved by SDS-PAGE under nonreducing conditions and the proteins were transferred to a nitro-
cellulose membrane. Immunoblotting was then performed with anti-z antibody 448. A portion of the total cell lysate was run in parallel to verify the
level of CD3-z expression. The position of the CD3-z homodimer is indicated by an arrow. The running positions of the molecular mass standards are
indicated with arrowheads.
Figure 3. TCR triggering elicits normal intracellular Ca21 increases in
apoptosis-deficient cells. Wild-type clones G7 and C3 and mutant clones
C2 and B5 loaded with the Ca21 sensitive dye fura-2 were stimulated
with 10 mg/ml OKT3 (first arrow), and when the peaks of intracytosolic
Ca21 began to decrease, a second stimulation was produced by adding 30
mg/ml of a rabbit anti–mouse Ig cross-linking antibody (second arrow).1184 Impaired ZAP70/CD3-z Interaction in Apoptosis-resistant Cells
cific antibodies. Thus, it was clear that PLC-g1 became ty-
rosine-phosphorylated upon activation of wild-type and
mutant clones. Since tyrosine phosphorylation activates
PLC-g1 (39-42), this result is consistent with the normal
intracellular Ca21 fluxes observed in mutant clones. Ty-
rosine phosphorylation of ZAP70 was also clearly induced
to wild-type levels in mutant clones, as well as tyrosine
phosphorylation of Vav, one of the ZAP70 binding pro-
teins (31, 43). A major difference between the wild-type
clone G7 and the mutant clone C2 was that a 50-kD pro-
tein was tyrosine phosphorylated at much higher levels in
the mutant clone. This protein had the mobility of b-tubu-
lin, as demonstrated after reprobing the membrane with a
specific antibody (data not shown). However, in other mu-
tant clones b-tubulin was not as heavily phosphorylated as
in C2, suggesting that it is not relevant to the apoptosis-
resistant phenotype. In summary, the Ca21 flux measure-
ments and the total protein tyrosine phosphorylation results
suggest that TCR triggering in mutant cells does not result
in a generalized lower production of second messengers,
and favors the existence of a specific signaling defect for
CD95-L induction.
Both Tyrosine-phosphorylated Forms of CD3-z Are Detected
in Apoptosis-deficient Cell Clones. Further experiments to
assess the level of tyrosine phosphorylation in wild-type
and mutant clones were performed by immunoprecipita-
tion with anti-phosphotyrosine antibodies from anti-CD3
stimulated cell lysates. As shown in Fig. 5 A, the immuno-
precipitation and immunoblotting with the antiphosphoty-
rosine antibody showed higher levels of total tyrosine-
phosphorylated proteins in mutant than in wild-type cells
(Fig. 5, left). Again, as in Fig. 4, a considerable level of con-
stitutive tyrosine phosphorylation was detected in nonstim-
ulated mutant cells. After reprobing the membrane with an
anti-z antibody it was found that the amount of CD3-z ho-
modimer that had been immunoprecipitated with the anti-
phosphotyrosine antibody was considerably reduced in
mutant cells (Fig. 5 A, right). This effect was specially clear
when the intensity of the CD3-z bands was compared with
those of the tyrosine-phosphorylated proteins. Note that
CD3-z is not one of the major tyrosine-phosphorylated
proteins and is not visualized in the film exposure shown in
Fig. 5 A.
There are marked differences in the patterns of tyrosine-
phosphorylated proteins obtained either after direct immu-
noblotting of a total lysate with the antiphosphotyrosine
antibody (Fig. 4) or by immunoblotting of an antiphospho-
tyrosine immunoprecipitate (Fig. 5 A). The differences
could be attributed to nonspecific binding of either the
anti-phosphotyrosine or the peroxidase-conjugated second
antibody to nontyrosine-phosphorylated bands; this could
hold true for the low molecular mass noninducible proteins
bands in Fig. 4. In addition, the immunoprecipitation with
the antiphosphotyrosine antibody could introduce a bias by
selecting the most heavily phosphorylated proteins or the
tyrosine-phosphorylated sequences for which the antibody
has higher affinity.
Since the mutation in the transmembrane domain of
TCR-b resulted in impaired association of CD3-z, it was
compelling to examine whether it became phosphorylated
to its low and high molecular mass forms. Therefore, a di-
rect immunoprecipitation under reducing conditions with
the anti-z antibody was performed from lysates of cells
stimulated with superantigen or with anti-CD3 antibody
(Fig. 5 B). As shown in this figure, although the levels of
tyrosine-phosphorylated CD3-z were consistently lower in
the mutant clone, both p18 and p21 phosphorylated forms
were detected. Furthermore, the ratio of p21 to p18 was
never lower in mutant than in wild-type cells. A control
for gel loading was established after reprobing the mem-
brane with the anti-z antibody. This demonstrated that the
amounts of immunoprecipitated CD3-z were equivalent in
Figure 4. TCR activation in apoptosis-
deficient cells results in high level of total
tyrosine phosphorylation. Wild-type G7
and mutant C2 cells were stimulated with
10 mg/ml OKT3 for the indicated times
and total cytoplasmic proteins were ob-
tained by acetone precipitation from deter-
gent cell lysates. The samples (equivalent to
3 3 105 cells per lane) were subjected to
SDS-PAGE and transferred to a nitrocellu-
lose membrane. Immunoblotting was per-
formed with antiphosphotyrosine antibody
4G10. Afterwards, the membrane was
stripped and sequentially reprobed with an-
tibodies specific for PLC-g1, Vav and
ZAP70. The position of b-tubulin was
identified in a separate experiment. Molecu-
lar mass standards are indicated by arrow-
heads.1185 Sahuquillo et al.
the wild-type and mutant clones (data not shown). Accord-
ing to these experiments, and unlike in altered peptide
ligands (APL)-stimulated T cell clones (44–46), CD3-z is
tyrosine-phosphorylated to its high molecular mass form.
Thus, in regard to the tyrosine phosphorylation of CD3-z,
the only difference observed between wild-type and mu-
tant clones was a decreased level of total phosphorylation in
the latter. Notwithstanding, it was surprising that despite its
low stoichiometry of association to the TCR complex (Fig.
2) CD3-z became tyrosine phosphorylated to relatively
high levels in the mutant clone (Fig. 5, A and B). A possi-
ble explanation for this discrepancy is that tyrosine-phos-
phorylated CD3-z could associate in the mutant clone to
the TCR complex with higher stoichiometry than non-
phosphorylated one. To control for the amount of ty-
rosine-phosphorylated CD3-z associated to the TCR com-
plex, an immunoprecipitation with anti–TCR-b antibody
was performed from wild-type and mutant clones stimu-
lated with anti-CD3 antibodies. As shown in Fig. 5 C, high
levels of the tyrosine-phosphorylated CD3-z dimer were
detected in the wild-type clone samples after activation
whereas in the mutant clone it was practically undetectable.
Thus, this result excludes the possibility that the TCR
complex preferably associates with phospho-z in the mu-
tant clone.
ZAP70 Becomes Tyrosine Phosphorylated in Apoptosis-defi-
cient Clones but Does Not Stably Associate to CD3-z. Although
ZAP70 appeared to become tyrosine-phosphorylated in
mutant cells (Fig. 4), it was compelling to test the level of
ZAP70 phosphorylation by direct immunoprecipitation
with a specific antibody. As shown in Fig. 6, after immu-
noprecipitation with an anti-ZAP70 antibody and immu-
noblotting with anti-phosphotyrosine, tyrosine-phosphor-
ylated proteins of 35–38 and 70 kD were detected in
samples from the wild-type clone G7 (Fig. 6, left). These
proteins were inducibly phosphorylated or inducibly asso-
ciated to ZAP70, although at different times after stimula-
tion. To identify these protein bands, the membrane was
stripped and reprobed sequentially with anti-ZAP70 and
anti-z antibodies (Fig. 6, right). Thus, the 70-kD band was
identified as ZAP70, whereas the mobility of the CD3-z
band did not correspond to any of the major tyrosine-
phosphorylated proteins.
Several differences were observed with the samples from
Figure 5. Both tyrosine phosphorylation forms of CD3-z are found at low lev-
els in apoptosis-deficient cells. (A) After activation of wild-type and mutant cells
with OKT3 for the indicated times, the cells were lysed and immunoprecipita-
tion was performed with anti-phosphotyrosine antibody PY20. The samples
were subjected to SDS-PAGE under nonreducing conditions. Immunoblotting
was afterwards carried out with anti-phosphotyrosine (P-Tyr) antibody 4G10
(left). The nitrocellulose membrane was stripped and reprobed with anti-z anti-
body 448 (right). (B) After activation with 10 mg/ml OKT3 or 10 mg/ml SEB,
the cells were lysed and immunoprecipitation was carried out with anti-z anti-
body 448. The samples were subjected to SDS-PAGE under reducing conditions
to resolve the high (p21) and low (p18) molecular mass forms of CD3-z.
Immunoblotting was performed with antiphosphotyrosine antibody 4G10.
NMS, non-immune serum used for control immunoprecipitation. (C) Wild-type
G7 and mutant C2 cells were stimulated with OKT3, lysed in 1% Brij96 and im-
munoprecipitation was performed with anti-Vb3 antibody Jovi.3. The immuno-
precipitates were resolved by SDS-PAGE under non-reducing conditions and
immunoblotting was performed with 4G10.1186 Impaired ZAP70/CD3-z Interaction in Apoptosis-resistant Cells
the mutant clone C2. Interestingly, higher levels of ty-
rosine-phosphorylated ZAP70 were detected in the mutant
clones (Fig. 6, left), even though the amount of immuno-
precipitated ZAP70 was equivalent (Fig. 6, right). Never-
theless, ZAP70 was tyrosine phosphorylated with similar
kinetics in each type of cell. These results show that ZAP70
becomes tyrosine phosphorylated in the mutant T cell
clones defective in induction of CD95-L. Interestingly, de-
spite the fact that ZAP70 becomes tyrosine phosphorylated,
its association to CD3-z in the mutant clone is negligible
(Fig. 6, right). Accordingly, the 35–38-kD tyrosine-phos-
phorylated protein that is found associated to ZAP70 both
in the wild-type and mutant clones must be a different pro-
tein. This protein may be pp36, a membrane-bound ty-
rosine-phosphorylated protein that has been described to
associate to the adapter Grb2, to PLC-g1, and to other
proteins (47–49). Nevertheless, the 35–38-kD phospho-
protein band runs fuzzier in the wild-type than in the mu-
tant samples, suggesting that the lowest part of the band
could correspond to tyrosine-phosphorylated CD3-z.
The anti-ZAP70 immunoprecipitations were repeated,
with similar results, using another wild-type and another
mutant clone obtained from an independent transfection
(data not shown). Although it has been established that
ZAP70 must be bound to tyrosine-phosphorylated ITAMs,
mainly of CD3-z, in order to become tyrosine-phosphory-
lated by one of the Src-family kinases associated to the
TCR complex or its coreceptors (5), the results shown in
Fig. 6 demonstrate that ZAP70 becomes tyrosine phosphor-
ylated in the mutant clone in the almost total absence of
CD3-z binding. It is possible that, in the mutant clones,
ZAP70 becomes tyrosine-phosphorylated after binding to
the ITAMs of other CD3 subunits or, alternatively, that
ZAP70 becomes tyrosine-phosphorylated after a transient
association with CD3-z.
To examine the kinase activities associated with ZAP70
in the mutant cell clones, an in vitro kinase assay was per-
formed with anti-ZAP70 immunoprecipitates obtained from
anti-CD3 stimulated cell samples. As shown in Fig. 7 A, a
phosphorylated 70-kD protein band was observed both in
wild-type and mutant clones, although the intensities of the
bands were somewhat lower in the immunoprecipitates
from the mutant clone samples. The 70-kD band, which
corresponded to ZAP70, as demonstrated after reprobing
with a specific antiserum (data not shown), was already
phosphorylated at low levels in nonactivated wild-type and
mutant cells, but its intensity increased after 1 min of acti-
vation in both types of cell. Most striking was the intensity
of two series of ZAP70-associated protein bands with mo-
lecular masses in the range of 18-21 and 22-24 kD that be-
came strongly phosphorylated in samples from stimulated
wild-type cells. After reprobing with specific antibodies, it
was demonstrated that the two bands just above the 17-kD
molecular mass marker corresponded to the two forms of
tyrosine-phosphorylated CD3-z, p18 and p21, and that the
strong phosphorylated protein band of 23 kD corresponded
to CD3-e (data not shown). However, although the sizes
of the 22- and 24-kD protein bands that run just below and
above CD3-e are reminiscent of the CD3-d and CD3-g
subunits, their identity could not be confirmed by probing
with specific antibodies, due to technical difficulties.
Since it has been shown that purified ZAP70 does not
phosphorylate CD3-z (50), the phosphorylation of this
chain in the in vitro kinase assay (Fig. 7 A) suggests the par-
ticipation of an inducible ZAP70-associated kinase differ-
ent to ZAP70. On the other hand, the fact that the CD3
ITAMs are not substrates for ZAP70 makes it difficult to
estimate the kinase activity of ZAP70 in the mutant clone
in the experiment shown in Fig. 7 A. To solve this prob-
lem, an exogenous substrate specific for ZAP70 (50) was
added to the in vitro kinase assay. As shown in Fig. 7 B, tu-
bulin was phosphorylated with similar efficiency in ZAP70
immunoprecipitates from wild-type and mutant cells, sug-
gesting that ZAP70 was equally active in both types of cell.
Interestingly, ZAP70 was constitutively more active in
samples from nonstimulated mutant cells (time 0) than
Figure 6. ZAP70 becomes tyrosine phos-
phorylated but does not associate to CD3-z
in apoptosis-deficient cells. Wild-type and
mutant cell clones were stimulated with 10
mg/ml OKT3 for the indicated times and
lysed in 1% Brij96-containing buffer. The
cell lysates were subjected to immunopre-
cipitation with anti-ZAP70 antiserum
ZAP4, the immunoprecipitates were re-
solved by SDS-PAGE under nonreducing
conditions, and the proteins were trans-
ferred to a nitrocellulose membrane. The
membrane was subsequently incubated with
antiphosphotyrosine antibody 4G10 (PTyr,
left), and later stripped and sequentially re-
probed with ZAP4 and anti-z antibody 448
(right). The running positions of molecular
mass standards, as well as of ZAP70, the
CD3-z homodimer (z2) and the immuno-
globulin heavy chain (H), are indicated.1187 Sahuquillo et al.
from the wild type, suggesting that ZAP70 could contrib-
ute to the higher level of constitutive general tyrosine
phosphorylation observed in mutant cells (Figs. 4 and 5 A).
Although there was an inducible kinase activity that
phosphorylated ZAP70 in mutant cell samples, the phos-
phorylation of CD3-e was strongly diminished, and both
forms of phosphorylated CD3-z were undetectable (Fig. 7 A).
In principle, the low level of phosphorylation in CD3-e
and CD3-z could be due either to low kinase activity in
the samples or to low concentration of these substrates.
This latter possibility seems to be correct since, after re-
probing the membrane, CD3-z and CD3-e were not de-
tected in the mutant clone samples (data not shown). Thus,
the results shown in Fig. 7 suggest that ZAP70 is active and
becomes tyrosine phosphorylated in mutant cells despite its
low-level association to CD3-z and other CD3 subunits.
ZAP70 Is Not Recruited to a Juxtamembrane Localization in
Apoptosis-deficient Cell Clones. Despite being mostly present
as a cytosolic protein, ZAP70 has been described to be in-
tracellularly located in a juxtamembrane position in acti-
vated lymphoblasts (51), Jurkat cells, and transfected fibro-
blasts (52). Although it could have been expected that
ZAP70 location in a juxtamembrane position depends on
binding to the phosphorylated ITAMs of the TCR–CD3
complex, it was demonstrated that a ZAP70 mutant de-
prived of the SH2 domains was still located near the mem-
brane (52). By contrast, a kinase dead mutant was not lo-
cated near the membrane, suggesting that this domain is
necessary for the localization of ZAP70 by a yet unknown
mechanism. To examine whether the low association of
ZAP70 to CD3-z in the mutant clones caused a misloca-
tion of ZAP70, wild-type and mutant cells were stimulated
for 1 min with anti-CD3 antibody and subsequently fixed,
permeabilized with saponin and stained with the anti-
ZAP70 antiserum. ZAP70 and CD3 stainings were ob-
served after incubation with fluoresceinated and Texas red–
labeled second antibodies, respectively. As shown in Fig.
8 A, ZAP70 was concentrated in a near-plasma membrane
location in most of the wild-type clone cells, whereas it re-
mained more evenly distributed throughout the cytosol in
most of the mutant clone cells and was not specially con-
centrated near the membrane. On the other hand, CD3
staining corresponded to a plasma membrane pattern, as was
expected. A higher magnification of single wild-type and
mutant cells is shown in Fig. 8 B. The observed patterns
obtained with the anti-peptide ZAP4 antibody were absent
in cells that had been stained in the presence of the com-
peting peptide, suggesting that they were specific (data not
shown). In addition, the ZAP70 staining patterns charac-
teristic of wild-type and mutant clones were reproduced by
a transfected HA-tagged ZAP70 construct (data not shown),
adding further support to their specificity.
Although the immunofluorescence data indicated that
ZAP70 was located near the plasma membrane in wild-
type cells, in a cell fractionation experiment it was mostly
found in a nonmembrane-bound cytosolic fraction (data
not shown), such as has been previously described (52). As
these authors proposed, the localization of ZAP70 near the
plasma membrane seems to be the result of a dynamic pro-
cess of association and dissociation to a yet unidentified re-
ceptor in the plasma membrane, rather than the result of
permanent binding. Accordingly, a ZAP70 gradient is gen-
erated. On the other hand, our results show that ZAP70 is
not concentrated near the plasma membrane in TCR-acti-
vated mutant cells where the association of ZAP70 to
CD3-z is impaired, suggesting that this binding might be
required for its localization near the plasma membrane in
Jurkat cells. In addition, these results suggest that the defec-
tive induction of CD95-L in mutant cells may derive from
the mislocation of ZAP70.
Figure 7. In vitro kinase assays. ZAP70 is not associated to CD3 sub-
units in apoptosis-deficient cells. (A) Wild-type and mutant clones were
stimulated with OKT3, lysed in 1% Brij96 and immunoprecipitation was
performed with anti-ZAP70 antiserum. The immunoprecipitates were
incubated with g-[32P]ATP in kinase buffer, washed, resolved by SDS-
PAGE under reducing conditions and transferred to a nitrocellulose
membrane. The membrane was dried and exposed to x-ray film. The po-
sitions of ZAP70, CD3-e and the p18 and p21 forms of CD3-z (arrow-
heads) were located by probing the membrane with specific antibodies.
NRS, nonimmune rabbit serum used as a control; H, immunoglobulin
heavy chain. (B) An in vitro kinase experiment was performed as in A but
8 mg per time point of purified bovine tubulin were added to the reaction
mixture. The positions of the phosphorylated ZAP70 and tubulin are in-
dicated.1188 Impaired ZAP70/CD3-z Interaction in Apoptosis-resistant Cells
Direct Stimulation of a CD3-z Chimera, but Not ZAP70
Overexpression, Reestablishes the Sensitivity of Mutant Cells to
Apoptosis. Since the defective induction of CD95-L and
apoptosis in Jurkat cells transfected with a plasma mem-
brane TCR-b point mutant may derive from the concom-
itant impaired association of CD3-z to the remaining sub-
units of the TCR complex, it was compelling to test
whether direct stimulation of CD3-z resulted in induction
of apoptosis. To this end, wild-type B7 and mutant C2
cells were transiently transfected with a Tac–z chimera that
contains the intracytoplasmic tail of CD3-z bound to the
extracellular and transmembrane domains of CD25. The
transfected cells were plated on anti-Tac–coated plastic
wells and the induction of apoptosis was measured 24 h
later by annexin V staining. As shown in Fig. 9 A, the per-
centage of annexin V and Tac double positive cells in-
creased to similar extents in wild-type and mutant cells after
stimulation with anti-Tac antibody. These results suggest
that the poor induction of apoptosis in mutant cells can be
overcome if CD3-z is directly stimulated, and reinforces
the idea that this poor induction results from a defective
transmission of the activation signal from the TCR to the
CD3-z chain. On the other hand, since ZAP70 is poorly
associated to CD3-z in apoptosis-resistant mutant cells, we
tried to determine whether overexpression of ZAP70
could overcome the apoptosis induction defect. To this
end, a ZAP70–GFP chimera was constructed, in order to
distinguish transfected from untransfected cells by flow
cytofluorimetry in a transient transfection assay. Wild-type
B7 and mutant C2 cells were transfected with either
ZAP70-GFP or GFP alone, and 24 h later the cells were
plated on anti-CD3 antibody-coated plastic wells. The per-
centage of apoptotic cells within the transfected population
was evaluated 20 h later by annexin V staining. As shown
in Fig. 9 B, the overexpression of ZAP70 resulted in en-
hanced induction of apoptosis in the wild type, but not in
the mutant clone. Interestingly, ZAP70 overexpression also
increased the level of basal apoptosis in nonstimulated wild-
type cells, suggesting that it is sufficient to trigger the apop-
tosis pathway. The results shown in Fig. 9 could be inter-
preted in terms of the impaired association of ZAP70 to
CD3-z in the mutant clones; the overexpression of ZAP70
did not result in an increased percentage of apoptotic cells
because the underlying association defect was not over-
come.
Discussion
In this paper we have analyzed early biochemical events
in an apoptosis-resistant variant of Jurkat cells as a tool for
dissecting possible pathways specific for the induction of
CD95-L. Since the variant was derived from transfection of
an amino acid substituted TCR-b cDNA that resulted in
impaired association of CD3-z, and because the CD3-z
homodimer contributes with six of the ITAMs of the
TCR–CD3 complex, it could have been expected that the
defective induction of CD95-L was the result of a general-
Figure 8. ZAP70 is not located near the plasma membrane in apopto-
sis-deficient cells. Wild-type and mutant cells were stimulated for 1 min
with 10 mg/ml OKT3, fixed, permeabilized, and stained with anti-
ZAP70 antiserum. The cells were then incubated with a Texas red–labeled
goat anti–mouse Ig antibody and with a fluoresceinated goat anti–rabbit
Ig antibody. A general field is shown in A, whereas magnifications of sin-
gle wild-type and mutant cells are shown in B. ZAP70 appears in green
and CD3 in red.1189 Sahuquillo et al.
ized lower production of second messengers. In other
words, a different requirement for second messenger levels
could be the basis for a defective CD95-L induction versus
IL-2 production. This was not the case, and similar levels
of intracellular Ca21 fluxes were recorded in wild-type and
mutant clones. These results are consistent with those de-
scribing the production of normal levels of IL-2 and Ca21
fluxes in murine T hybridomas that express a CD3-z chain
deprived of the cytoplasmic tail (38). Furthermore, the lev-
els of total protein tyrosine phosphorylation were never
lower in the mutant than in the wild-type clones, thus sug-
gesting that impaired CD95-L production results from al-
teration of a specific signaling pathway. Although the puta-
tive specific pathway, necessary for CD95-L induction but
not for cytokine production nor for expression of activa-
tion antigens, has not yet been characterized, we have
found two specific alterations in mutant cells: first, a lower
level of tyrosine phosphorylation of CD3-z; second, and
more important, a lower level of ZAP70/CD3-z associa-
tion.
The fact that CD3-z becomes phosphorylated, albeit at
low level, despite its low stoichiometry of association to the
other chains of the complex, suggests that CD3-z becomes
transiently associated to the complex and then phosphory-
lated. Alternatively, either isolated CD3-z or CD3-z asso-
ciated to other membrane receptors could become tyrosine
phosphorylated by a trans-acting mechanism. Although we
do not yet know which of these possibilities is correct, we
favor the idea of the existence of an equilibrium of associa-
tion of CD3-z on the cell surface that is displaced towards
dissociation in cells expressing the TCR-b mutant. It
would be in the TCR-associated form when CD3-z be-
comes phosphorylated. Interestingly, CD3-z was found in
its two tyrosine-phosphorylated forms of 18 and 21 kD in
the apoptosis-deficient clones, contrarily to the findings on
T cell clones stimulated with partial agonists, where only
the lower molecular mass form of tyrosine-phosphorylated
CD3-z was detected (44–46).
The involvement of CD3-z in the induction of apoptosis
through the TCR complex has been shown earlier (27,
28). Although the components of the TCR–CD3 complex
may be in part functionally redundant, we believe our data
and those of Combadière et al. (27) suggest the existence of
a specialized role for CD3-z in the induction of CD95-L.
Furthermore, the data of Combadière et al. (27) showed
that the membrane-proximal ITAM of CD3-z (ITAM1),
and not the others, was effective in the induction of apop-
tosis. These results suggest that the functional specialization
within the TCR–CD3 complex can be narrowed down
not only to individual subunits but to particular regions of
these subunits as well. In line with this idea, previous works
in vitro have shown that different ITAMs of the TCR–
CD3 complex have different affinities for components of
the transduction machinery, including ZAP70 and the p85
subunit of PI 3-kinase (6, 8, 53). A further degree of spe-
cialization was made evident by Sunder-Plassman et al.
(54), who showed that the NH2-terminal and COOH-ter-
minal YxxL/I sequences within ITAM1 of CD3-z may
each trigger different activation events.
In addition to a different pattern of CD3-z tyrosine
phosphorylation, in APL-stimulated T cell clones ZAP70
was not tyrosine phosphorylated (44, 45). By contrast, in the
apoptosis-deficient clones ZAP70 became tyrosine phos-
phorylated to similar or even higher levels than in wild-
type clones. Although the impaired induction of CD95-L
and apoptosis were not paralleled by a defective tyrosine
phosphorylation of ZAP70, two results seem to link this ty-
rosine kinase to the underlying apoptosis induction defect.
First, the stoichiometry of ZAP70/CD3-z association was
very low in apoptosis-defective mutants. Second, in these
Figure 9. Direct stimulation
of a Tac–z chimera, but not
ZAP70 overexpression, results in
apoptosis of the apoptosis-defi-
cient cells. (A) Apoptosis
through a Tac–z chimera. Wild-
type and mutant cell clones were
transiently transfected with a
Tac–z chimera and 24 h later
were stimulated with plastic-
bound anti-Tac antibody (striped
bars) or left unstimulated (filled
bars). 20 h later the percentage of
cells in apoptosis within the Tac–
z-transfected population was
measured by annexin V staining.
(B) Effect of ZAP70 overexpres-
sion on apoptosis induction.
Wild-type B7 (open symbols) and
mutant C2 (filled symbols) cell
clones were transiently trans-
fected with plasmids expressing either a ZAP70-GFP fusion protein (continuous lines) or GFP (broken lines). 24 h after electroporation the cells were plated
on wells precoated with the indicated concentrations of OKT3, and 20 h later, the percentage of apoptotic cells within the transfected populations was
measured by annexin V staining.1190 Impaired ZAP70/CD3-z Interaction in Apoptosis-resistant Cells
mutants, ZAP70 is not found in a near-plasma membrane
location. Tyrosine phosphorylation of ZAP70 is believed
to be performed by Src family tyrosine kinases once ZAP70
is bound to tyrosine-phosphorylated CD3-z (reviewed in
references 2, 3). Our findings in the apoptosis-deficient
mutants are apparently contradictory to this idea, since
ZAP70 becomes inducibly tyrosine phosphorylated even at
higher levels than in wild-type cells, despite the fact that
ZAP70 association to CD3-z and to the other subunits of
the TCR complex is very poor. It may be that in the mu-
tant cells ZAP70 associates transiently to the TCR com-
plex, and that this association is sufficient for ZAP70 to be-
come tyrosine phosphorylated and activated. It could also
be speculated that the higher levels of tyrosine-phosphory-
lated ZAP70 detected in the mutant cells could be due to
mislocation of ZAP70 that would make it less accessible to
tyrosine phosphatases such as SHP-1, which binds and de-
phosphorylates ZAP70 (55). The differential induction of cy-
tokines versus CD95-L in the apoptosis-resistant cells could
thus derive from a quantitative difference in the levels of
membrane-bound ZAP70. Alternatively, the differential
signaling may derive from a different orientation adopted
by ZAP70, since it has recently been suggested that ZAP70
may “sense” in this way different TCR ligands (56).
The tyrosine kinase activity of ZAP70 has recently been
shown to be essential for TCR triggering of apoptosis via
CD95-L expression (57) and, according to our data, the lo-
calization of ZAP70 near the plasma membrane is also nec-
essary for the induction of CD95-L ligand. In this regard, it
has been shown that the permanent association of ZAP70
to the plasma membrane by transfection of a CD2/ZAP70
chimera results in constitutive activation of the NFAT
transcription factor and apoptosis (58). Thus, we could hy-
pothesize the existence of a ZAP70 substrate, located at or
near the plasma membrane, necessary for the induction of
CD95-L expression. The transient recruitment of ZAP70
to the plasma membrane in the mutant cells would cause a
deficit in the recruitment or in the phosphorylation of that
substrate. So far, we do not know the identity of this possi-
ble substrate, since the pattern of total tyrosine-phosphory-
lated proteins is very similar to that of wild-type cells. It has
been described that ZAP70 recruitment to the plasma
membrane does not involve its SH2 domains and needs its
kinase activity intact (52). These results imply the existence
of a membrane-bound ZAP70 substrate that, once phos-
phorylated, may promote the localization of ZAP70 near
the plasma membrane. The translocation of ZAP70 to the
plasma membrane in fibroblasts, in the complete absence of
T cell–specific components, argues strongly against an in-
volvement of the TCR–CD3 complex. However, we have
found in our mutant cells a correlation between impaired
ZAP70 association to CD3-z and mislocation of ZAP70.
Thus, it is likely that the association to CD3-z is indirectly
involved, at least in T cells, in the localization of ZAP70
near the plasma membrane; perhaps as a requisite for the
tyrosine phosphorylation of the putative membrane-bound
ZAP70 substrate. Nevertheless, it is still possible that the
strongly diminished binding of ZAP70 to CD3-z and the
mislocation of ZAP70 observed in the mutant cells are in-
dependent processes. Overexpression of ZAP70 in the mu-
tant clones, unlike in the wild-type ones, does not result in
increased apoptosis, perhaps because the defective recruit-
ment of ZAP70 to the cell surface is not bypassed. By con-
trast, the transfection and direct stimulation of a Tac–z chi-
mera results in an induction of apoptosis comparable to that
found in transfected wild-type cells. This result supports
the hypothesis that the defective induction of apoptosis in
the mutant clones results from an impaired recruitment of
CD3-z to the TCR complex.
The expression of CD95-L is inhibited by cyclosporin A
treatment (21–23) and is not induced in NFATp-deficient
mice (24), strongly suggesting that it is dependent on
NFAT transcription factors. Indeed, an inducible NFAT-
binding site has been demonstrated in the CD95-L pro-
moter (25). Thus, the regulation of the CD95-L gene ex-
pression seems to be very similar to that of cytokine genes.
Furthermore, the induction of CD95-L expression is de-
pendent on early signals that involve Lck (59, 60) and
CD45 (25), as well as the participation of the ras pathway
(25). Nevertheless, the inducible NFAT-binding site in the
CD95-L promoter is more reminiscent of that of the TNF-a
promoter than the IL-2 promoter (25). For instance, the
CD95-L promoter does not contain a predicted AP-1–bind-
ing site in the proximity of the NFAT site. Against this
background, it seems clear that the fine regulation of CD95-L
versus IL-2 expression is dependent on rather subtle differ-
ences. The results shown in this paper and Rodríguez-Tar-
duchy et al. (28) show that it is possible to distinguish be-
tween the two pathways, and that the signaling pathways
diverge very early in the signaling cascade, involving the
ZAP70/CD3-z interaction. The unstable interaction of
ZAP70 with CD3-z may cause an unbalanced cascade of
phosphorylations, which may be detrimental for CD95-L
expression but not for induction of IL-2 expression and for
other activation events. Interestingly, it has recently been
proposed that Lck, but not Fyn, may mediate a signaling
activation pathway that results in CD95-L upregulation
and apoptosis (60). Since it has been shown that tyrosine-
phosphorylated ZAP70 recruits Lck through its SH2 do-
main (11, 51), an intriguing possibility is that CD95-L is
not induced in the apoptosis-deficient cells analyzed here
because Lck is not recruited by ZAP70. In support of this
idea, it has been shown that Lck lies downstream of ZAP70
when apoptosis is triggered by permanent localization of
ZAP70 near the plasma membrane (58).
Our results suggest that a point mutation in the trans-
membrane domain of TCR-b impairs the association of
CD3-z, and that this is translated into transient association
of ZAP70. This association is sufficient for activation of
ZAP70 and to elicit the gene expression of IL-2, IFN-g,
CD25, and CD69, but not for induction of CD95-L. We
are at present trying to characterize the pathway that links
ZAP70 with CD95-L induction, and which must be inac-
tive in the apoptosis-resistant cells.1191 Sahuquillo et al.
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